TokenPost·
Frontier Medicines Reports 56% Response Rate in Phase 1 Lung Trial
56%
response rate
The confirmed responses came in 10 of 18 evaluable patients with metastatic non-small cell lung cancer treated after chemotherapy and immunotherapy.
More news
- TokenPostTwo Measures Put xStocks at $610.9 Million and $885.7 Million
- TokenPostBitGuru Flags Zcash Resistance and Three Lower Price Levels
- CryptoPotatoJamie Dimon Hated Bitcoin: JPMorgan Now Expects BTC to Beat Stocks and Gold
- Crypto BriefingxStocks tokenized stocks hit $1B in onchain market cap, up 802.5% in a year
- CryptopolitanKevin Hassett says US-Canada trade negotiations are gaining momentum
- TokenPostEther Breaks Above $2,350 as Binance Spot Price Reaches $2,352